OlgaBrawman-MintzerMD
Psychiatry • Charleston, SCProfessor, Psychiatry and Behavioral Sciences, Medical University of South Carolina College of Medicine
Are you Dr. Brawman-Mintzer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Summary
- Dr. Olga Brawman-Mintzer, MD is a board certified psychiatrist in Charleston, South Carolina. She is currently licensed to practice medicine in South Carolina and Florida. She is affiliated with Roper Hospital and Roper St. Francis Mount Pleasant Hospital.
Education & Training
Medical University of South CarolinaResidency, Psychiatry, 1991 - 1993
University of Miami/Jackson Health SystemResidency, Psychiatry, 1987 - 1991
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1985
Certifications & Licensure
SC State Medical License 1991 - 2025
FL State Medical License 1990 - 2000- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly Start of enrollment: 2005 Oct 01
- Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2.Shankar Tumati, Nathan Herrmann, Jaime Perin, Paul B Rosenberg, Alan J Lerner
International Psychogeriatrics. 2024-09-19 - 5 citationsComparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.George I Papakostas, Madhukar H Trivedi, Richard C Shelton, Dan V Iosifescu, Michael E Thase
Molecular Psychiatry. 2024-08-01 - Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial).Lijuan Zeng, Jamie Perin, Alden L Gross, David Shade, Krista L Lanctôt
International Journal of Geriatric Psychiatry. 2024-06-01
Press Mentions
Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019
